GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Currently predicting for Mon, 22 Apr 2024

AKAO Predictions History

4 years ago
PumpTheseNumbers predicted that AKAO for 2019-05-16 is going $0.0780 (-23.15%)

4 years ago
JS predicted that AKAO for 2019-05-16 is going $0.0900 (-11.33%)

4 years ago
PumpTheseNumbers predicted that AKAO for 2019-04-30 is going $0.153 (42.99%)

4 years ago
PumpTheseNumbers predicted that AKAO for 2019-04-29 is going $0.109 (-5.22%)

4 years ago
JS predicted that AKAO for 2019-04-29 is going $0.0510 (-55.65%)

4 years ago
NameNotImportant predicted that AKAO for 2019-04-29 is going $0.0800 (-2.44%)

4 years ago
Chris.Rodriguez.109229 predicted that AKAO for 2019-04-29 is going $0.416 (407.32%)

Rank:

4 years ago
NameNotImportant predicted that AKAO for 2019-04-24 is going $0.0510 (-52.60%)

5 years ago
JS predicted that AKAO for 2019-04-17 is going $0.155 (-15.76%)

5 years ago
PumpTheseNumbers predicted that AKAO for 2019-04-15 is going $0.483 (210.21%)

Click to get the best stock tips daily for free!

About Achaogen

Achaogen, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antibacterials to treat multi-drug resistant (MDR) gram-negative infections in the United States. The company is principally developing plazomicin, which is in Phase III clinical trial for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. It is also involved in the resear... AKAO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT